Literature DB >> 30106114

miR‑197 promotes the invasion and migration of colorectal cancer by targeting insulin‑like growth factor‑binding protein 3.

Na Zhou1, Zhao Sun2, Ningning Li2, Yuping Ge2, Jianfeng Zhou2, Qin Han3, Lin Zhao2, Chunmei Bai2.   

Abstract

The incidence and mortality of colorectal cancer (CRC) have been rising rapidly in China. A number of miRNAs have been confirmed to be involved in diverse biological processes of CRC. However, whether miR‑197 plays a role in migration and invasion of CRC has never been explored. In the present study Transwell chambers were used in in vitro migration and invasion assays. Dual-luciferase reporter assay was employed to confirm the target of miR‑197. RT‑PCR and IHC staining were performed to quantify miR‑197 and IGFBP3 expression, respectively. Clinicopathological features were collected for statistical analysis. We observed that the overexpression of miR‑197 significantly promoted migration and invasion in 3 CRC cell lines including HCT8, HCT116 and SW480 (P<0.05), while the inhibition of miR‑197 weakened both biological processes (P<0.05). In bioinformatics and dual-luciferase reporter assay, luciferase activities of IGFBP3‑WT‑transfected cells significantly decreased upon miR‑197 overexpression and this inhibitory effect was abolished when miR‑197 binding region in IGFBP3 3'‑UTR was mutated, which indicated that miR‑197 directly suppressed the expression of IGFBP3 in CRC cells by targeting its 3'UTR. Downregulation of the expression of IGFBP3 by using targeted siRNA led to significant enhancement of cell migration and invasion in two CRC cell lines including HCT8 and HCT116 (P<0.05). Finally, in cancerous tissues of CRC patients, the miR‑197 level was inversely correlated with the expression of IGFBP3 (P=0.026), which indicated that miR‑197 may modulate cell migration and invasion by targeting IGFBP3 in CRC patients. In conclusion, we revealed that miR‑197 modulates IGFBP3 and therefore plays a critical role in regulating CRC migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30106114     DOI: 10.3892/or.2018.6640

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  6 in total

Review 1.  Noncoding RNA actions through IGFs and IGF binding proteins in cancer.

Authors:  Aidan Kerr; Robert C Baxter
Journal:  Oncogene       Date:  2022-05-21       Impact factor: 8.756

2.  microRNA-222 promotes colorectal cancer cell migration and invasion by targeting MST3.

Authors:  Fei Luo; Jianfeng Zhou; Shihua Wang; Zhao Sun; Qin Han; Chunmei Bai
Journal:  FEBS Open Bio       Date:  2019-04-02       Impact factor: 2.693

3.  Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.

Authors:  Zizhen Zhang; Sheng Zheng; Yifeng Lin; Jiawei Sun; Ning Ding; Jingyu Chen; Jing Zhong; Liuhong Shi; Meng Xue
Journal:  BMC Cancer       Date:  2020-11-23       Impact factor: 4.430

4.  miR-197 Participates in Lipopolysaccharide-Induced Cardiomyocyte Injury by Modulating SIRT1.

Authors:  Miaomiao Liu; Ying Zhang; Xiantong Cao; Tao Shi; Yang Yan
Journal:  Cardiol Res Pract       Date:  2022-02-17       Impact factor: 1.866

5.  Hsa_circ_0039569 facilitates the progression of endometrial carcinoma by targeting the miR-197/high mobility group protein A1 axis.

Authors:  Yi Zhou; Anyi Pan; Yudong Zhang; Xinchun Li
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

6.  Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma.

Authors:  Rong Ma; Yanyun Zhao; Miao He; Hongliang Zhao; Yifan Zhang; Shuqi Zhou; Mengcong Gao; Di Di; Jue Wang; Jian Ding; Minjie Wei
Journal:  Cancer Cell Int       Date:  2019-12-30       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.